Antihypertensive Therapeutics in Major Developed Markets to 2020 - Increased Uptake of Combination Therapies to Offset Effects of Key Patent Expiries - PowerPoint PPT Presentation

Loading...

PPT – Antihypertensive Therapeutics in Major Developed Markets to 2020 - Increased Uptake of Combination Therapies to Offset Effects of Key Patent Expiries PowerPoint presentation | free to download - id: 7d74c6-ZWNhN



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

Antihypertensive Therapeutics in Major Developed Markets to 2020 - Increased Uptake of Combination Therapies to Offset Effects of Key Patent Expiries

Description:

This report provides in-depth analysis of hypertension therapeutics market within the eight major geographies of the US, the top five European countries (the UK, France, Germany, Spain and Italy), Japan and Canada. The report provides an estimation of market size for 2013, along with market forecast until 2020. It also covers disease epidemiology, treatment algorithms, treatment patterns, in-depth analysis of the pipeline, and deal analysis. – PowerPoint PPT presentation

Number of Views:3

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Antihypertensive Therapeutics in Major Developed Markets to 2020 - Increased Uptake of Combination Therapies to Offset Effects of Key Patent Expiries


1
Antihypertensive Therapeutics in Major Developed
Markets to 2020 - Increased Uptake of Combination
Therapies to Offset Effects of Key Patent Expiries
Single User License - 4995 Site User
License - 9990 Corporate User License -
14985 Publication Date - Jun 2014 Pages -
91 To know more details, email to
debora_at_reportstack.com
2
Summary
  • This report provides in-depth analysis of
    hypertension therapeutics market within the eight
    major geographies of the US, the top five
    European countries (the UK, France, Germany,
    Spain and Italy), Japan and Canada. The report
    provides an estimation of market size for 2013,
    along with market forecast until 2020. It also
    covers disease epidemiology, treatment
    algorithms, treatment patterns, in-depth analysis
    of the pipeline, and deal analysis.
  • The value of the hypertension market in the major
    developed markets amounted to an estimated 40.0
    billion in 2013 and is expected to decline during
    the forecast period at a negative Compound Annual
    Growth Rate (CAGR) of 0.9 to 37.6 billion in
    2020, with growth expected from 2013 to 2017 at a
    CAGR of 2.6 and a decline thereafter.

3
Scope
- Disease overview, as well as treatment
algorithms and treatment use patterns - Market
size and forecast for the hypertension market
from 2013-2020 - Major marketed products for
hypertension along with a heat map of product
performance - In-depth pipeline analysis for
global pipeline in hypertension along with
clinical trial failure rate analysis - Key
drivers and restraints that have had and are
expected to have a significant impact upon the
market - Key licensing and co-development
agreements that could have impact on growth trends
4
Key Benefits
- Align your product portfolio to the markets
with high growth potential - Develop market entry
and expansion strategies by identifying the
potential regions and therapeutic segments poised
for strong growth - Devise a more effectively
tailored country strategy through the
understanding of key drivers and barriers in the
hypertension therapeutics market - Develop key
strategic initiatives based upon an understanding
of key focus areas and leading companies -
Accelerate and strengthen your market position by
identifying key companies for mergers,
acquisitions and strategic partnerships
5
If you are interested...
Contact Debora White Email
debora_at_reportstack.com Ph1-888-789-6604 http/
/www.reportstack.com
About PowerShow.com